PALLADINO, SILVIA
PALLADINO, SILVIA
Dipartimento di Scienze Biomolecolari (DISB)
2206P Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1
2023 Palladino, S.; Ruzzo, A.; Emili, R.; Catalano, V.; De Lisa, M.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R.
Detection of circulating KRAS4A and KRAS4B isoforms in patients with metastatic lung adenocarcinoma treated with pembrolizumab or chemotherapy plus pembrolizumab by liquid biopsy: Clinical impact and association with circulating PD-L1
2023 Palladino, S.; Ruzzo, A.; Emili, R.; Catalano, V.; De Lisa, M.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R.
Expression of circulating KRAS-4a and KRAS-4b mRNA isoforms in Patients with metastatic lung adenocarcinoma treated with Pembrolizumab or chemotherapy plus Pembrolizumab by liquid biopsy. Clinical impact and assoociation with circulating Pd-L1
2023 Palladino, S.; Ruzzo, A.; Emili, R.; De Lisa, M.; Catalano, V.; Leva, G.; Sarti, D.; Magnani, M.; Graziano, F.; Chiari, R.
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
2023 Chiari, Rita; Palladino, Silvia; Emili, Rita; De Lisa, Mariagrazia; Sarti, Donatella; Catalano, Vincenzo; Magnani, Mauro; Graziano, Francesco; Ruzzo, Annamaria
KRAS4A, KRAS4B and PD-L1 circulating mRNA analysis and association with progression free survival in a population of metastatic NSCLC patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab by Liquid Biopsy
2023 Palladino, Silvia
THE EXPRESSION OF THE KRAS mRNA ISOFORMS 4A AND 4B IN PLASMA: A COMPARISON BETWEEN LUNG ADENOCARCINOMA PATIENTS AND HEALTHY DONORS THROUGH LIQUID BIOPSY
2021 Palladino, S.; Graziano, F.; Bagaloni, I.; Emili, R.; Catalano, V.; Furlò, G.; Lippe, P.; Sarti, D.; Magnani, M.; Ruzzo, A.